Piramal to Acquire Hemmo Pharmaceuticals, Adding Peptide API Manufacturing to CDMO Arm
Piramal Pharma Limited acquires Hemmo Pharmaceuticals for INR 775 crores, marking its CDMO arm’s entry into peptide API manufacturing. The deal adds 30+ APIs and a GMP-certified facility.